Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Biogen Idec Inc

+ Add to Watchlist

BIIB:US

409.590 USD 0.510 0.12%

As of 20:10:00 ET on 02/27/2015.

Company Profile for Biogen Idec Inc (BIIB)

Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.

Contact Information

Biogen Idec Inc

225 Binney Street
Cambridge, MA 02142
United States
Phone: 781-464-2000

Key Executives for Biogen Idec Inc (BIIB)

George A ScangosChief Executive OfficerSusan H AlexanderExec VP/Chief Legal Ofcr/Secy
Paul J ClancyExec VP:Finance/CFOAdriana Karaboutis "Andi"Exec VP:Tech & Bus Solutions
Stephen H Holtzman "Steve"Exec VP:Corporate DevelopmentDouglas Edward Williams "Doug"Exec VP:Research & Dev
Stuart A Kingsley "Tony"Exec VP:Global Commercial OpsJohn G CoxExec VP:Pharmaceutical
Kenneth Di PietroExec VP:Human ResourcesAdam M KoppelSenior VP/Chief Strategy Ofcr
Alfred W Sandrock JrSenior VP/Chief Medical OfcrSpyros Artavanis-TsakonasSenior VP/Chief Scientific Ofcr
Gregory F CovinoVP:Finance/Chief Acctg OfcrKaren JewellInvestor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil